NuuVim review
Oral access at parity with injectable pricing for both molecules — genuinely uncommon — at a standing $79/$133 new-patient tier, though the follow-on refill rate isn't published and NuuVim's own state coverage couldn't be confirmed live despite WLR's directory claiming all 50 states.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
NuuVim at a glance
- Semaglutide
- $79/mo
- Tirzepatide
- $133/mo
- Coverage
- Not disclosed
- Start
- Not disclosed
How we scored NuuVim
Each factor is scored from NuuVim's real pricing, disclosures and intake flow, then combined into the 47/100 Rx-Readiness Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No approval or shipping timeline is published anywhere on the site.
The new-patient entry price is clearly published, but the site itself signals a different, unpublished refill-tier rate follows — undermining predictability.
Nothing found states whether the required review happens by video or asynchronously.
WLR's directory claims all 50 states plus DC, but this could not be independently confirmed on NuuVim's own live site — marked not verified by observation.
Both semaglutide and tirzepatide are offered, each in both injectable and oral form at price parity, plus brand-name options.
No cancellation or pause policy is published anywhere on the site.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.nuuvim.com
Live site, fetched directly. Texas-based DTC telehealth. LegitScript-certified, HIPAA-compliant. Site states 'NuuVim does not manufacture compounded medications.' Oral access is offered at price parity with injectable for both molecules — genuinely uncommon in this category. WLR's own directory description asserts 'all 50 states plus DC' but that claim could not be verified directly on NuuVim's live site during this check — not repeated here as verified; marked not verified by observation. Solid compounding disclaimer present verbatim: 'Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality.' No FDA warning letter found in a live search run 2026-08-05.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $79 | New GLP-1 users (injectable or oral, same price)'Starting at $79/mo | New GLP-1 Users' — a standing new-patient tier, not a countdown-timer promo. A different, unpublished 'current user' refill tier likely applies after the first fill, since the site itself frames it that way without publishing the follow-on number. |
| Compounded tirzepatide | $133 | New GLP-1 users (injectable or oral, same price)'Starting at $133/mo | New GLP-1 Users,' same standing-tier caveat as semaglutide above — the refill-rate number is not published. |
| Brand semaglutide | $1498 | Brand OzempicPriced far above LillyDirect/NovoCare manufacturer self-pay channels. |
| Brand tirzepatide | $1892 | Brand ZepboundPriced far above LillyDirect/NovoCare manufacturer self-pay channels. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect NuuVim's public disclosures at last review and change often; confirm the current number on NuuVim's own site.
What we like
- Oral access at price parity with injectable for both semaglutide and tirzepatide — a genuinely uncommon menu in this category
- LegitScript-certified and HIPAA-compliant
- The $79/$133 new-patient tier is a standing pricing structure, not a countdown-timer promo
- Brand-name Ozempic and Zepbound available for patients who want an FDA-approved option, even though priced high
The caveats
- The $79/$133 pricing is explicitly a new-patient tier; NuuVim's own site frames a separate, unpublished 'current user' refill rate as applying afterward
- State coverage could not be independently verified live, despite WLR's directory asserting all 50 states plus DC
- Brand-name Ozempic ($1,498/mo) and Zepbound ($1,892/mo) are priced far above LillyDirect/NovoCare manufacturer self-pay channels
- No approval or shipping timeline is published anywhere on the site
NuuVim for working moms: our verdict
Oral access at parity with injectable pricing for both molecules — genuinely uncommon — at a standing $79/$133 new-patient tier, though the follow-on refill rate isn't published and NuuVim's own state coverage couldn't be confirmed live despite WLR's directory claiming all 50 states. It runs about $79/month — toward the affordable end of what we track.
We weigh NuuVim the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic weight-loss review skips.
What NuuVim actually costs
- Compounded semaglutide — New GLP-1 users (injectable or oral, same price): $79/mo
- Compounded tirzepatide — New GLP-1 users (injectable or oral, same price): $133/mo
- Brand-name semaglutide — Brand Ozempic: $1498/mo
- Brand-name tirzepatide — Brand Zepbound: $1892/mo
That sits below the roughly $175 median ongoing price across the providers we track for working moms — a real cost advantage.
The medications NuuVim prescribes
NuuVim prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters because you can switch between them without re-enrolling or hunting for a new provider mid-plan. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own labeling, though the brand price runs well above the compounded tiers.
A needle-free oral or sublingual option is on the menu, which draws in working moms who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where NuuVim fits — and where it doesn't — for working moms
A good fit if…
- the monthly line on your budget is a real barrier and you want a low, predictable number.
Look elsewhere if…
- you'd rather the most predictable place to start and pause — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for working moms: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
NuuVim is a genuine value play — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Working moms who want a genuine oral option at the same price as the injectable and are comfortable that the refill-month price isn't published up front.
Alternatives to NuuVim
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
- Visit Telos RxRx-Readiness86100
A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.
Keep comparing NuuVim
Head-to-head & alternatives
NuuVim, answered
- Is NuuVim's $79/$133 price permanent?
- It's a standing 'New GLP-1 Users' tier, not a countdown-timer promo, so it's fair to treat as the real entry price. But NuuVim itself frames a separate, unpublished 'current user' refill tier as applying after your first fill — budget for the number to change at renewal, since it isn't disclosed.
- Does NuuVim serve all 50 states?
- That's a claim in WLR's provider directory, but it could not be independently verified on NuuVim's own live site during this check. Confirm your state directly with NuuVim rather than assuming nationwide coverage.
- Can I get brand-name Ozempic or Zepbound through NuuVim?
- Yes, but at $1,498/mo and $1,892/mo respectively — both priced well above what you'd pay through LillyDirect or NovoCare's own manufacturer self-pay programs directly. The compounded options at $79–$133/mo are the more competitive lane here.
Pricing, states and verification reflect NuuVim's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.